ProText Mobility, Inc. (TXTM)

OTCMKTS · Delayed Price · Currency is USD
0.0007
-0.0001 (-12.50%)
Apr 23, 2025, 2:07 PM EDT
-61.11%
Market Cap 6.15M
Revenue n/a
Net Income n/a
Shares Out 8.79B
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 675,522
Average Volume 3,647,077
Open 0.0008
Previous Close 0.0008
Day's Range 0.0007 - 0.0008
52-Week Range 0.0001 - 0.0023
Beta -3.21
RSI 46.43
Earnings Date n/a

About ProText Mobility

ProText Mobility, Inc., a biotech company, engages in the development of pharmaceutical botanical medicines. Its medicines are formulated with highly-bioavailable plant extracts. The company is based in Fort Lauderdale, Florida. ProText Mobility, Inc. operates as a subsidiary of Plandaí Biotechnology, Inc. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Roger Baylis-Duffield
Country United States
Stock Exchange OTCMKTS
Ticker Symbol TXTM
Full Company Profile

News

PROTEXT MOBILITY ANNOUCNES SIGNING OF LETTER OF INTENT TO ACQUIRE PREMIER VODKA BRAND

Boca Raton, Florida, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Protext Mobility, Inc. (OTC PINK: TXTM) is pleased to announce it has executed a Letter of Intent to acquire 100% ownership of a premier vodka Br...

3 years ago - GlobeNewsWire